Latest accounts payable for BOLD: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Boundless Bio posts a accounts payable of $0 as of March 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Boundless Bio's accounts payable was $0. The latest reading is $0 (period ending March 2026). Use the history and growth charts on this page for a longer lookback.
Accounts Payable is one piece of Boundless Bio's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for BOLD's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Boundless Bio's other metric pages and overview cover the third.